vs
PUMA BIOTECHNOLOGY, INC.（PBYI）とSECURITY NATIONAL FINANCIAL CORP（SNFCA）の財務データ比較。上の社名をクリックして会社を切り替えられます
SECURITY NATIONAL FINANCIAL CORPの直近四半期売上が大きい（$83.0M vs $75.5M、PUMA BIOTECHNOLOGY, INC.の約1.1倍）。PUMA BIOTECHNOLOGY, INC.の前年同期比売上増加率が高い（27.7% vs 4.7%）。SECURITY NATIONAL FINANCIAL CORPの直近四半期フリーキャッシュフローが多い（$43.8M vs $14.4M）。過去8四半期でPUMA BIOTECHNOLOGY, INC.の売上複合成長率が高い（31.3% vs 1.1%）
プーマ・バイオテクノロジーは上場済みの生物医薬品企業で、本社はアメリカ合衆国カリフォルニア州ロサンゼルスに位置し、革新的な医薬品の研究開発を中心に事業を展開しています。
CNOフィナンシャル・グループ（旧コンセコ社）は、アメリカ合衆国インディアナ州カーメルを本拠とする金融サービス持株会社です。傘下の保険子会社は米国の400万人以上の顧客に生命保険、年金、補足健康保険商品を提供しており、独立代理店、専属代理店のほか、テレビ広告やダイレクトメールを通じて直接顧客に販売しています。
PBYI vs SNFCA — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $75.5M | $83.0M |
| 純利益 | — | $13.5M |
| 粗利率 | 69.3% | 98.6% |
| 営業利益率 | 22.7% | 20.9% |
| 純利益率 | — | 16.3% |
| 売上前年比 | 27.7% | 4.7% |
| 純利益前年比 | — | 430.9% |
| EPS（希薄化後） | $0.26 | $0.52 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $75.5M | $83.0M | ||
| Q3 25 | $54.5M | $89.3M | ||
| Q2 25 | $52.4M | $89.5M | ||
| Q1 25 | $46.0M | $82.7M | ||
| Q4 24 | $59.1M | $79.3M | ||
| Q3 24 | $80.5M | $88.3M | ||
| Q2 24 | $47.1M | $85.8M | ||
| Q1 24 | $43.8M | $81.2M |
| Q4 25 | — | $13.5M | ||
| Q3 25 | $8.8M | $7.8M | ||
| Q2 25 | $5.9M | $6.5M | ||
| Q1 25 | $3.0M | $4.3M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $20.3M | $11.8M | ||
| Q2 24 | $-4.5M | $7.3M | ||
| Q1 24 | $-4.8M | $7.5M |
| Q4 25 | 69.3% | 98.6% | ||
| Q3 25 | 77.7% | 98.8% | ||
| Q2 25 | 76.5% | 98.7% | ||
| Q1 25 | 77.1% | 98.5% | ||
| Q4 24 | 76.4% | 98.5% | ||
| Q3 24 | 63.9% | 98.7% | ||
| Q2 24 | 77.4% | 98.6% | ||
| Q1 24 | 75.5% | 98.4% |
| Q4 25 | 22.7% | 20.9% | ||
| Q3 25 | 17.6% | 11.4% | ||
| Q2 25 | 12.7% | 9.3% | ||
| Q1 25 | 8.7% | 6.7% | ||
| Q4 24 | 22.6% | 4.0% | ||
| Q3 24 | 27.4% | 17.2% | ||
| Q2 24 | -4.6% | 10.9% | ||
| Q1 24 | -5.3% | 11.8% |
| Q4 25 | — | 16.3% | ||
| Q3 25 | 16.2% | 8.7% | ||
| Q2 25 | 11.2% | 7.3% | ||
| Q1 25 | 6.5% | 5.2% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 25.2% | 13.4% | ||
| Q2 24 | -9.6% | 8.5% | ||
| Q1 24 | -11.0% | 9.2% |
| Q4 25 | $0.26 | $0.52 | ||
| Q3 25 | $0.17 | $0.31 | ||
| Q2 25 | $0.12 | $0.25 | ||
| Q1 25 | $0.06 | $0.18 | ||
| Q4 24 | $0.40 | $0.09 | ||
| Q3 24 | $0.41 | $0.47 | ||
| Q2 24 | $-0.09 | $0.29 | ||
| Q1 24 | $-0.10 | $0.31 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $97.5M | $102.3M |
| 総負債低いほど良い | $22.7M | — |
| 株主資本純資産 | $130.3M | $410.4M |
| 総資産 | $216.3M | $1.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.17× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $97.5M | $102.3M | ||
| Q3 25 | $94.4M | $100.4M | ||
| Q2 25 | $96.0M | $79.3M | ||
| Q1 25 | $93.2M | $132.9M | ||
| Q4 24 | $101.0M | $140.5M | ||
| Q3 24 | $96.7M | $170.7M | ||
| Q2 24 | $96.8M | $143.6M | ||
| Q1 24 | $107.2M | $150.9M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $410.4M | ||
| Q3 25 | $115.3M | $365.4M | ||
| Q2 25 | $104.7M | $354.8M | ||
| Q1 25 | $97.1M | $346.5M | ||
| Q4 24 | $92.1M | $381.9M | ||
| Q3 24 | $71.1M | $346.3M | ||
| Q2 24 | $48.5M | $325.8M | ||
| Q1 24 | $51.0M | $320.1M |
| Q4 25 | $216.3M | $1.6B | ||
| Q3 25 | $202.9M | $1.6B | ||
| Q2 25 | $194.9M | $1.5B | ||
| Q1 25 | $196.2M | $1.5B | ||
| Q4 24 | $213.3M | $1.5B | ||
| Q3 24 | $220.7M | $1.5B | ||
| Q2 24 | $205.0M | $1.5B | ||
| Q1 24 | $214.1M | $1.4B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $14.4M | $45.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $14.4M | $43.8M |
| FCFマージンFCF / 売上 | 19.1% | 52.8% |
| 設備投資強度設備投資 / 売上 | 0.0% | 2.0% |
| キャッシュ転換率営業CF / 純利益 | — | 3.38× |
| 直近12ヶ月FCF直近4四半期 | $41.7M | $69.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $14.4M | $45.5M | ||
| Q3 25 | $9.7M | $25.6M | ||
| Q2 25 | $14.1M | $-7.7M | ||
| Q1 25 | $3.6M | $9.6M | ||
| Q4 24 | $15.6M | $57.3M | ||
| Q3 24 | $11.0M | $26.8M | ||
| Q2 24 | $1.0M | $-17.0M | ||
| Q1 24 | $11.2M | $25.1M |
| Q4 25 | $14.4M | $43.8M | ||
| Q3 25 | $9.7M | $24.9M | ||
| Q2 25 | $14.1M | $-8.1M | ||
| Q1 25 | $3.6M | $9.1M | ||
| Q4 24 | $15.6M | $54.8M | ||
| Q3 24 | $11.0M | $26.6M | ||
| Q2 24 | $1.0M | $-17.1M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | 19.1% | 52.8% | ||
| Q3 25 | 17.7% | 27.9% | ||
| Q2 25 | 26.8% | -9.1% | ||
| Q1 25 | 7.7% | 11.1% | ||
| Q4 24 | 26.4% | 69.2% | ||
| Q3 24 | 13.7% | 30.2% | ||
| Q2 24 | 2.1% | -20.0% | ||
| Q1 24 | — | 30.6% |
| Q4 25 | 0.0% | 2.0% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.0% | 0.3% |
| Q4 25 | — | 3.38× | ||
| Q3 25 | 1.10× | 3.28× | ||
| Q2 25 | 2.41× | -1.18× | ||
| Q1 25 | 1.21× | 2.21× | ||
| Q4 24 | — | 22.55× | ||
| Q3 24 | 0.54× | 2.26× | ||
| Q2 24 | — | -2.33× | ||
| Q1 24 | — | 3.36× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PBYI
セグメントデータなし
SNFCA
| Life Insurance | $29.9M | 36% |
| Mortgage | $24.8M | 30% |
| Other | $21.3M | 26% |
| Timing Of Revenue Recognition Goods Transferred At A Point In Time | $4.6M | 6% |
| Timing Of Revenue Recognition Services Transferred At A Point In Time | $2.4M | 3% |
